COV1001
COVID-19 Investigational Vaccine Study
This study is assessing two different dosages of an investigational COVID-19 vaccine (Ad26COVS1) in healthy adults. The main purpose is to determine if the study vaccine is safe and if any reactions occur. This trial completed enrollment in August 2020 and is ongoing.